Catheter Precision (VTAK) SC 13GRa Medical Systems / R. Randall Rollins Voting Trust U/A dated August 25, 1994 ownership change

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1)       Includes 261,553 shares of Common Stock held by RFT Investment Company, LLC. The Gary W. Rollins Voting Trust U/A dated September 14, 1994 (the “GWR Voting Trust”) has a 50% voting interest in LOR, Inc., which is the manager of RFT Investment Company, LLC. Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

(1)       Includes 261,553 shares of Common Stock held by RFT Investment Company, LLC. The R. Randall Rollins Voting Trust U/A dated August 25, 1994 (the “RRR Voting Trust”) has a 50% voting interest in LOR, Inc., which is the manager of RFT Investment Company, LLC. Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

]

(1)       Includes 261,553 shares of Common Stock held by RFT Investment Company, LLC. LOR, Inc. is the manager of RFT Investment Company, LLC. Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

(1)       Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

Item 1(a). Name of Issuer:

Ra Medical Systems, Inc. (the “Issuer”)

Item 1(b). Address of Issuer’s Principal Executive Offices:

1670 Highway 160 West

Suite 205

Fort Mill, SC 29708 

Item 2(a). Name of Person Filing:

Gary W. Rollins Voting Trust U/A dated September 14, 1994 (the “GWR Voting Trust”)

R. Randall Rollins Voting Trust U/A dated August 25, 1994 (the “RRR Voting Trust”)

LOR, Inc.

RFT Investment Company, LLC

Item 2(b). Address of Principal Business Offices or, if none, Residence:

GWR Voting Trust

c/o RFA Management Company, LLC

1908 Cliff Valley Way, NE

Atlanta, Georgia 30329

RRR Voting Trust

c/o RFA Management Company, LLC

1908 Cliff Valley Way, NE

Atlanta, Georgia 30329

LOR, Inc.

c/o RFA Management Company, LLC

1908 Cliff Valley Way, NE

Atlanta, Georgia 30329

RFT Investment Company, LLC

c/o RFA Management Company, LLC

1908 Cliff Valley Way, NE

Atlanta, Georgia 30329

Item 2(c). Citizenship:

GWR Voting Trust – United States

RRR Voting Trust – United States

LOR, Inc. – Georgia

RFT Investment Company, LLC – Georgia

Item 2(d). Title of Class of Securities:

Common Stock, $0.0001 Par Value

Item 2(e). CUSIP Number:

74933X302

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a), (b), and (c):

The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for the Reporting Person hereto and is incorporated herein by reference. The percentage set forth in Row 11 of the cover page for the Reporting Person is based on 4,984,093 shares of the Common Stock issued and outstanding as of March 23, 2023 as reported in the Issuer’s Form 10-K for the fiscal year ended December 31, 2022 filed with the Securities and Exchange Commission on March 28, 2023.

Item 5.    Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.    Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable

Item 8.    Identification and Classification of Members of the Group.

Not applicable

Item 9.    Notice of Dissolution of Group.

Not applicable

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

EXHIBIT A

Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of this Amendment to Schedule 13G, including further amendments thereto, with respect to the shares of Common Stock, $0.0001 par value per share, of Ra Medical Systems, Inc. and further agrees that this Joint Filing Agreement be filed with the Securities and Exchange Commission as an exhibit to such filing; provided, however, that no person shall be responsible for the completeness or accuracy of the information concerning the other persons making the filing unless such person knows or has reason to believe such information is inaccurate (as provided in Rule 13d-1(k)(1)(ii)). This Joint Filing Agreement may be executed in one or more counterparts, all of which together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the persons named below have executed this Joint Filing Agreement as of the date set forth below.